Duloxetine (Cymbalta) for treatment of major depressive disorder

American Family Physician

Volumn 72, Issue 6, 2005, Pages 1099-1102

  Cobb, Carla ^a   Crichlow, Renee ^a  

^a Montana Family Medicine Residency   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIARRHYTHMIC AGENT; DESIPRAMINE; DULOXETINE; ESCITALOPRAM; FLECAINIDE ACETATE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PLACEBO; PROPAFENONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE; THIOPHENE DERIVATIVE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL TRIAL; DIABETIC NEUROPATHY; DIZZINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; EUROPE; FOOD AND DRUG ADMINISTRATION; HUMAN; INSOMNIA; KIDNEY FAILURE; MAJOR DEPRESSION; NAUSEA; NEUROPATHIC PAIN; ORGASM DISORDER; PERIPHERAL NEUROPATHY; REVIEW; SEXUAL DYSFUNCTION; SOMNOLENCE; STRESS INCONTINENCE; UNITED STATES; ARTICLE; ECONOMICS; FEMALE; MALE; METABOLISM; TREATMENT OUTCOME;

DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; SEROTONIN UPTAKE INHIBITORS; THIOPHENES; TREATMENT OUTCOME;

EID: 26944499084     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (8)

1. Raskin J, Goldstein DJ, Mallinckrodt CH, Ferguson MB. Duloxetine in the long-term treatment of major depressive disorder. J Clin Psychiatry 2003;64:1237-44.
2. Eli Lilly and Company. Cymbalta (duloxetine) package insert. Accessed online July 12, 2005, at: http://pi.lilly.com/us/cymbalta-pi.pdf.
3. Detke MJ, Lu Y, Goldstein DJ, Hayes JR, Demitrack MA. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial. J Clin Psychiatry 2002;63:308-15.
4. Goldstein DJ, Lu Y, Detke MJ, Wiltse C, Mallinckrodt C, Demitrack MA. Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine. J Clin Psychopharmacol 2004;24:389-99.
5. Goldstein DJ, Mallinckrodt C, Lu Y, Demitrack MA. Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial. J Clin Psychiatry 2002;63:225-31.
6. Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I. Duloxetine in the acute and longterm treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Eur Neuropsychopharmacol 2004;14:457-70.
7. Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004;50:2974-84.
8. Dmochowski RR, Miklos JR, Norton PA, Zinner NR, Yalcin I, Bump RC, and the Duloxetine Urinary Incontinence Study Group. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence [published correction appears in J Urol 2004;171:360]. J Urol 2003;170(4 pt 1):1259-63.